Covid in Scotland: Roll-out of Moderna vaccine begins in Glasgow

Scottish government confirmed that under-30s will be offered an alternative to the AstraZeneca jab

The UK's third coronavirus vaccine, the Moderna jab, has been administered in Scotland for the first time.

National clinical director Prof Jason Leitch said the vaccine had been given to patients at the Hydro in Glasgow.

It came as the Scottish government confirmed that under-30s will be offered an alternative to the AstraZeneca jab. It follows a review by the UK drugs regulator which found a possible link between the jab and rare blood clots.

By the end of March, it found that 79 people had suffered rare blood clots after vaccination - 19 of whom had died. The regulator said this was not proof the jab had caused the clots - but the link was getting firmer.

Meanwhile, scientists developing a Covid vaccine being manufactured in Scotland reported a 90% immune response in early trials.

Biotech company Valneva tested its vaccine on 153 people and concluded it was safe and generally well-tolerated. The roll-out of the Moderna vaccine began in Wales, where unpaid carer Elle Taylor was the first to receive the jab.

Prof Leitch said "relatively low numbers" received the vaccine in Glasgow on Wednesday but its use will increase. On the AstraZeneca vaccine, he stressed that its benefits outweigh its risks and it continues to be a safe and effective vaccine. The 79 cases of blood clots and 19 deaths occurred after 20 million doses were administered - giving a risk of about four in one million of developing a blood clot, and one in a million of dying.

Prof Leitch said that the under the 30s with no underlying health conditions would now be offered either a Moderna or Pfizer vaccine.

"We haven't started that group yet so we have time to plan and put in place what we will need in order to be able to them the two alternative vaccines we have just now and maybe in the not too distant future some other vaccines," he said.

His deputy, Nicola Steedman, said they were considering whether the move may affect the timescales of the vaccination programme but they remain on track to offer first injections to all adults before the end of July.

"We continue to urge anyone offered a vaccination to take up their appointment," she added.

"Everyone who has received their first dose of the AstraZeneca vaccine should receive their second dose as this gives greater and longer-lasting protection against the virus.

"This is with the exception of the very few individuals who have had a blood clot with low platelet counts after their first injection, or an allergic reaction."

Meanwhile, Valneva said it will move to phase three of its vaccine trials by testing up to 5,000 people, some of whom will be recruited in Scotland.

UK Health Secretary Matt Hancock said if approved, the vaccine would play an "important role" in protecting communities.

Valneva, which manufactures its Covid vaccine at a plant in Livingston, said the results of their phase one/two study showed the vaccine was "highly immunogenic with more than 90% of all study participants developing significant levels of antibodies" to the Covid virus spike protein.

What is happening at Scotland's Covid vaccine lab?

Those who received a medium dose of the vaccine showed an 89.8% immune response, while people given a high dose showed a 100% response. The vaccine also induced T-cell responses, which help the body fend off a virus and play a role in long-lasting immunity.

No safety concerns were identified by an independent data safety monitoring board.

Story Source: 

Tags : #Scottishgovernment #LatestCOVIDVaccineNews10thApr #MattHancock #Valneva #VaccineBloodClots #VaccinationDriveinScotland #AstraZeneca #Moderna

About the Author

Team Medicircle

Related Stories

Loading Please wait...


Trending Now

Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023
Global Corporate Summit 2023 with the theme Unlocking Opportunities in a Dynamic World heldNovember 16, 2023
2nd IHub-Data Mobility Summit heldNovember 16, 2023
Revolutionary AI-powered technology detects multiple abdominal pathologies simultaneouslyNovember 16, 2023
1 Out of 3 Stroke Patients Suffer Long-Term Health Complications, Says NeurologistNovember 16, 2023
Amrita Hospital, Kochi, Launches App for People with Swallowing DifficultiesNovember 15, 2023